Invention Grant
- Patent Title: Angiopoietin-like 4 antibodies and methods of use
-
Application No.: US15686454Application Date: 2017-08-25
-
Publication No.: US10577411B2Publication Date: 2020-03-03
- Inventor: John Trauger , Andrei Igorevich Voznesensky
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Meghan S. Adams
- Main IPC: C07K16/18
- IPC: C07K16/18 ; C07K16/22 ; A61K39/00
Abstract:
The present invention relates to monoclonal antibodies binding to human angiopoietin-like 4 protein (hereinafter, sometimes referred to as “ANGPTL4”), and pharmaceutical compositions and methods of treatment comprising the same.
Public/Granted literature
- US20180044410A1 ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE Public/Granted day:2018-02-15
Information query
